Table 3.

Treatment and outcome characteristics of patients

	Group 1	Group 2	P
Treatment
Hydroxychloroquine, n (%)	25 (86.2)	44 (84.6)	.054
Oseltamivir, n (%)	24 (82.7)	41 (80.7)	.052
Antibiotics, a n (%)	24 (82.7)	44 (84.6)	.054
Antiviral treatment
Lopinavir‐ritonavir, n (%)	8 (27.6)	6 (11.5)	.123
Favipravir, n (%)	5 (17.2)	3 (5.8)	.127
Tocilizumab, n (%)	3 (10.3)	4 (7.7)	.697
Corticosteroids, n (%)	3 (10.3)	4 (7.7)	.697
Outcome
Hospitalization, n (%)	29 (100)	17 (32.7)	.000
Transfer to ICU, n (%)	6 (20.7)	2 (3.8)	.022
Hospital length of stay, d	6.4	3.4	.000
Mortality n (%)	2 (6.9)	1 (1.9)	.290

Note: Bold values are statistically significant.

Abbreviation: ICU, intensive care unit.

^a Antibiotics: azithromycin or moxifloxacin.